skip to Main Content
Anatomy of Curaleaf’s marijuana production blunder that sickened more than a dozen in Oregon: Here’s how it happened

A calamitous mix-up at a Portland marijuana bottling plant apparently originated with a single employee who confused two similar buckets with nearly identical identification numbers, according to a state investigative report.

The report does not specify, though, whether manufacturer Curaleaf had any quality control measures in place to catch such mistakes, and state investigators withheld some key details of their findings.

Nevertheless, the report – obtained by The Oregonian/OregonLive through a public records request – is the first direct account of how Curaleaf confused bottles of marijuana drops with those containing CBD, a wellness product that doesn’t have psychoactive properties.

Following Curaleaf’s blunder, at least a dozen people who thought they were taking benign CBD drops reporting becoming ill after ingesting jumbo doses of THC, the psychoactive ingredient in marijuana.

At least five customers reported going to the emergency room after taking the mislabeled drops; two said they were driving when they were incapacitated by an unexpected marijuana high.

Curaleaf maintains that it complied with state safety requirements, but in a statement this week acknowledged its responsibility in the incident and described several new safety procedures. Among other reforms, Curaleaf said it now tests samples before selling its products. [Read More @ The Oregonian]

This Post Has 0 Comments

Leave a Reply

Your email address will not be published.

Recent Stories

The Cannabusiness Key June Webcast: The State of Cannabis Capital Markets and M&A

The following is a transcript of The Cannabusiness Key “The State of Cannabis Capital Markets and M&A” webcast, which aired on June 29, 2022. It has been edited for clarity. For more information, and to register to view the archived webinar, please go here. 2022 has been a volatile year up and down the global…

European CBD Applications Will Require ‘Complicated And Huge’ Human Studies, Admit EFSA

FOLLOWING the European Food Safety Authority’s (EFSA) controversial decision to ‘stop the clock’ on all CBD novel food applications last month, the regulator addressed the industry in a virtual public forum last week. In what EFSA referred to as an effort to begin ‘an open dialogue with stakeholders’, the ‘info session’ sought to shed some…

My Conversation With A Cannabis Social Media Expert

Is social media worth the time, money, and effort to build brand awareness in the cannabis industry when borders are closed, and the rules are so restrictive? Today we’re talking to our social media partner, Amy Donohue from Hybrid Social, to discuss why social media is the place to build brand, community, and authenticity through…

California Cannabis Lender License Requirements

by Griffen Thorne, Attorney at Harris Bricken Cannabis businesses need money – and lots of it – to operate. Being mostly startups, operational profits are not enough to sustain their business. So cannabis businesses take on outside capital generally in one of two ways: taking on debt from cannabis lenders or bringing in equity investors.…

More Categories

Back To Top
×Close search
Search